Medigate is the leading IoT and cybersecurity company for devices in the healthcare industry, enabling providers to deliver secure, connected care. Medigate merges knowledge and understanding of medical workflow and device identity and protocols with the reality of today's cybersecurity threats. Through Medigate, hospital networks can securely operate all medical devices on their network, enabling the deployment of new devices to patients while ensuring privacy and security.
Medigate announces the closing of a $30 million Series B financing round, led by technology investor PartechThe company is globally recognised for its expertise in driving the growth of innovative and technology-driven companies.
In addition to Partech, former investors such as: YL VenturesThe investor funds and supports brilliant Israeli cybersecurity tech entrepreneurs from start-up to leadership, U.S. Venture Partners (USVP)a leading Silicon Valley venture capital firm, and Blumberg Capitala growing venture capital firm that partners with entrepreneurs who are passionate about innovating and building successful technology companies. As such, the company has raised a total of $50 million, including capital raised in the Series A funding round closed in 2019.
Thanks to the capital raised, Medigate will continue to develop its goal of becoming the leading security and analytics company in the medical sector. As the volume and speed of data generated by IoT and medical devices increases, healthcare organisations are expanding their digital strategies to include technologies such as wearable devices designed for patient monitoring or mobile devices used in telemedicine systems. Providing them with a single, end-to-end solution will not only help strengthen security throughout the cycle, but also provide analytics to drive operational efficiency, corporate effectiveness, CapEx and OpEx reduction or improve patient experience.
EN 
ES